News
Monster Beverage Falls Flat Despite Record Sales
For companies that are considered the growth darlings of the stock market, higher revenue is not enough. Growth rates also have to remain strong, and energy-drink giant Monster Beverage (NASDAQ: MNST)
CVS Health Corporation's PBM Strong, but Retail Business Weak in 2nd Quarter
CVS Health (NYSE: CVS) didn't disappoint the last time the pharmacy giant announced its quarterly results. The company's profit was down in the first quarter, but still beat expectations. Still, CVS
Who Are Mondelez International’s Biggest Shareholders?
Take a look at Mondelez International's (NASDAQ: MDLZ) largest shareholder list and you'll find typical large institutional holders such as BlackRock, a New York-based money manager that owns 5.8% of
Who Are Mondelez International’s Biggest Shareholders?
Take a look at Mondelez International's (NASDAQ: MDLZ) largest shareholder list and you'll find typical large institutional holders such as BlackRock, a New York-based money manager that owns 5.8% of
Who Are Mondelez International’s Biggest Shareholders?
Take a look at Mondelez International's (NASDAQ: MDLZ) largest shareholder list and you'll find typical large institutional holders such as BlackRock, a New York-based money manager that owns 5.8% of
Why Altria Group, Inc. Stock Dropped 13% Last Month
Shares of Altria Group (NYSE: MO) were getting smoked last month after the tobacco giant turned in an underwhelming earnings report and reacted to surprising news from the Food and Drug
GROUPE BOGART : Revenus du 1er semestre 2017 : 61,2 M EUR en croissance de +17,5%
Le Groupe Bogart (Euronext Paris - Compartiment B - FR0012872141 - JBOG), spécialisé dans la création, la fabrication et la commercialisation de parfums et de produits cosmétiques de luxe,....
GROUPE BOGART : INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE
ART. L233-8-II du code de commerce et ART 222-12-5 du règlement général de l'AMF
Dénomination sociale de l'émetteur : JBOG
Nature des titres : ISIN FR0012872141
DATE....
Can SodaStream Keep Going After Last Week's 9% Pop?
SodaStream (NASDAQ: SODA) continues to execute on the mother of all second acts. The company behind the carbonated beverage maker saw its shares rise 9.2% last week, moving higher after another
What It Means for Mondelez That CEO Irene Rosenfeld Is Leaving
In this Market Foolery segment, host Chris Hill and Motley Fool Funds' Bill Barker attempt to read the tea leaves around the departure of Mondelez's (NASDAQ: MDLZ) longtime CEO. Her replacement is
What It Means for Mondelez That CEO Irene Rosenfeld Is Leaving
In this Market Foolery segment, host Chris Hill and Motley Fool Funds' Bill Barker attempt to read the tea leaves around the departure of Mondelez's (NASDAQ: MDLZ) longtime CEO. Her replacement is
What It Means for Mondelez That CEO Irene Rosenfeld Is Leaving
In this Market Foolery segment, host Chris Hill and Motley Fool Funds' Bill Barker attempt to read the tea leaves around the departure of Mondelez's (NASDAQ: MDLZ) longtime CEO. Her replacement is
3 Things You Should Watch For in CVS Health's Q2 Update
A rebuilding year.That's how CVS Health (NYSE: CVS) CEO Larry Merlo has referenced 2017 in the past. The rebuilding is needed because the large pharmacy services company lost two major contracts in
Budweiser Taps Into Local Trend With New Beer Label Design
Anheuser-Busch InBev (NYSE: BUD) recently unveiled a creative way to confront beer drinker preference for locally brewed suds: it is producing limited-time-only labels for its Budweiser brand that
Balchem Corporation's Business Is Getting Healthier in 2017
Balchem Corporation (NASDAQ: BCPC) had a nearly flawless quarter, with only one segment shrinking versus a year ago. And even that weakness will likely be short-lived.As growth gains steam, the bottom
The FDA's New Nicotine Proposal Spells Trouble for Big Tobacco
The more than 50-year war that's been waged by the U.S. against tobacco companies has been working. According to the latest statistics from the Centers for Disease Control and Prevention (CDC), an
Why Allscripts Healthcare Solutions, Inc. Gained 12.4% Today
After announcing better-than-expected sales, an acquisition, and increased guidance for 2017, shares in Allscripts Healthcare Solutions (NASDAQ: MDRX) rallied 12.4% higher today.Allscripts
Why AmerisourceBergen Corp. Fell Dramatically Today
AmerisourceBergen (NYSE: ABC) closed down 10.5% on Thursday after announcing disappointing fiscal third-quarter earnings and reducing its expectations for revenue for the entire fiscal 2017. Fellow
What Drove Kellogg Co.'s Bottom-Line Beat and Stock Price Rise?
Shares of Kellogg Co. (NYSE: K), a leading global producer of cereal, cookies, crackers, and other packaged foods, closed Thursday up a healthy 4.3% after the company reported better-than-expected
Why Fitbit, SodaStream International, and Stamps.com Jumped Today
The stock market once again finished with mixed performance on Thursday, as major benchmarks moved in different directions. Weakness in technology stocks pulled the Nasdaq Composite down more than
SodaStream Second-Quarter Earnings Jump 84%
Heading into this week's earnings report, SodaStream (NASDAQ: SODA) investors showed growing optimism that the at-home beverage machine company would sustain its market-beating ways. The 45% stock
Why PharMerica Stock Is Soaring Today
Following word that private equity firm KKR (NYSE: KKR) will acquire the company for $29.25 per share in cash (plus the assumption or repayment of debt), shares of PharMerica Corporation (NYSE: PMC)
Why PharMerica Stock Is Soaring Today
Following word that private equity firm KKR (NYSE: KKR) will acquire the company for $29.25 per share in cash (plus the assumption or repayment of debt), shares of PharMerica Corporation (NYSE: PMC)
Why PharMerica Stock Is Soaring Today
Following word that private equity firm KKR (NYSE: KKR) will acquire the company for $29.25 per share in cash (plus the assumption or repayment of debt), shares of PharMerica Corporation (NYSE: PMC)
Why PharMerica Stock Is Soaring Today
Following word that private equity firm KKR (NYSE: KKR) will acquire the company for $29.25 per share in cash (plus the assumption or repayment of debt), shares of PharMerica Corporation (NYSE: PMC)